Cacti Therapeutics
PrivateLast Round
Accelerator
Jan 1, 2024
Total Funding Raised
$100,000
Company Overview
Cacti Therapeutics is a biotechnology company developing novel non-addictive pharmaceutical therapies for chronic pain, inflammation, and opioid use disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cacti Therapeutics Comparables
Compare Cacti Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ella LeRoy Corporation | 79% |
Cacti Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jan 1, 2024 |
Cacti Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capital Factory | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 15, 2025
Grew 93% QoQ from 15 to 29 employees.
- Jan 18, 2025
Grew 75% QoQ from 16 to 28 employees.
Cacti Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cacti Therapeutics's valuation, stock price, and market status.
Is Cacti Therapeutics a public or private company?
Cacti Therapeutics is a private company.
What is the current stock price of Cacti Therapeutics?
Cacti Therapeutics is a private company with no public stock price. Caplight tracks Cacti Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Cacti Therapeutics worth (valuation)?
Valuation information for Cacti Therapeutics is not publicly available.
Can I buy Cacti Therapeutics stock?
Cacti Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cacti Therapeutics's last funding round?
Cacti Therapeutics's most recent funding round was Accelerator on January 1, 2024.
Who are the main investors in Cacti Therapeutics?
Key investors in Cacti Therapeutics include Capital Factory.
Will Cacti Therapeutics IPO soon?
No public IPO plans have been announced for Cacti Therapeutics.
How can I track Cacti Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cacti Therapeutics's secondary market activity and sign up for updates.